The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; 1 of the 50 sources its claims cite were checked for support.
PDGF signalling controls age-dependent proliferation in pancreatic β-cells
Open accessAbstract
Determining the signalling pathways that direct tissue expansion is a principal goal of regenerative biology. Vigorous pancreatic β-cell replication in juvenile mice and humans declines with age, and elucidating the basis for this decay may reveal strategies for inducing β-cell expansion, a long-sought goal for diabetes therapy. Here we show that platelet-derived growth factor receptor (Pdgfr) signalling controls age-dependent β-cell proliferation in mouse and human pancreatic islets. With age, declining β-cell Pdgfr levels were accompanied by reductions in β-cell enhancer of zeste homologue 2 (Ezh2) levels and β-cell replication. Conditional inactivation of the Pdgfra gene in β-cells accelerated these changes, preventing mouse neonatal β-cell expansion and adult β-cell regeneration. Targeted human PDGFR-α activation in mouse β-cells stimulated Erk1/2 phosphorylation, leading to Ezh2-dependent expansion of adult β-cells. Adult human islets lack PDGF signalling competence, but exposure of juvenile human islets to PDGF-AA stimulated β-cell proliferation. The discovery of a conserved pathway controlling age-dependent β-cell proliferation indicates new strategies for β-cell expansion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
71 Own result · 32 Own interpretation · 31 Not checked yet · 7 Own method · 1 Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“With age, declining β-cell Pdgfr levels were accompanied by reductions in β-cell enhancer of zeste homologue 2 (Ezh2) levels and β-cell replication.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Adult human islets lack PDGF signalling competence, but exposure of juvenile human islets to PDGF-AA stimulated β-cell proliferation.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Adult human islets lack PDGF signalling competence, but exposure of juvenile human islets to PDGF-AA stimulated β-cell proliferation.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Conditional inactivation of the Pdgfra gene in β-cells accelerated these changes, preventing mouse neonatal β-cell expansion and adult β-cell regeneration.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Conditional inactivation of the Pdgfra gene in β-cells accelerated these changes, preventing mouse neonatal β-cell expansion and adult β-cell regeneration.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Conditional inactivation of the Pdgfra gene in β-cells accelerated these changes, preventing mouse neonatal β-cell expansion and adult β-cell regeneration.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Targeted human PDGFR-α activation in mouse β-cells stimulated Erk1/2 phosphorylation, leading to Ezh2-dependent expansion of adult β-cells.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“βPdgfαKO mice at 3 weeks had mild hyperglycaemia during ad libitum feeding and impaired glucose tolerance in a glucose challenge test (Supplementary Fig. 3e, f).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Age-dependent β-cell Pdgfr-α loss
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By 3 months, β-cell Ezh2 expression had declined in control mice, but β-cell Ezh2 expression in βPDGFRαTg mice was maintained at elevated levels, a difference that persisted for 8–14 months (Fig. 3e, f).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGFR-α promotes functional β-cell expansion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, islet mRNAs encoding the insulin receptor, prolactin receptor, glucocorticoid receptor and intrinsic regulators of β-cell proliferation like Pdx1, Foxo1, Foxo3, Rb1 (hereafter referred to as Rb), p130 (also known as Rbl2) and E2f1, did not decline in mice with advancing age (Supplementary Fig. 2).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Age-dependent β-cell Pdgfr-α loss
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Every source the paper cites for this claim was checked and supports it.
In the paper
“β-cell mass and proliferation were morphometrically quantified13 by independent researchers blinded to sample identity.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > METHODS SUMMARY > Histology, immunohistochemistry and molecular studies
What the sources say
- Supportedcites [13] Chen, H. et al. Polycomb protein Ezh2 regulates pancreatic β-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 23, 975–985 (2009) source
The citation is attached to “morphometrically quantified.” The Histology, immunofluorescence, and immunohistochemistry section describes morphometric measurement of β-cell mass and BrdU-positive β-cells as a measure of proliferation. The subsequent statement about independent, blinded researchers is not attached to this citation. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, neither β-cell BrdU incorporation nor mass were increased in βEzh2KO-RαTg mice compared to controls (Fig. 4c, d and Supplementary Fig. 7).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF-induced β-cell expansion requires Ezh2
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Islet PDGFRAD842V mRNA levels in both βEzh2KO-RαTg and βEzh2HET-RαTg mice were elevated and indistinguishable (Fig. 4a).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF-induced β-cell expansion requires Ezh2
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, total pancreatic mass and islet architecture in βPDGFRαTg mice and controls were indistinguishable (Supplementary Figs 5c and 6b).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGFR-α promotes functional β-cell expansion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“PDGF/ERK signalling activates cell cycle regulators to stimulate proliferation24,25, and βPDGFRαTg islets had elevated levels of Ccnd1 mRNA encoding cyclin D1, and increased β-cells with nuclear cyclin D1 and phosphorylated Rb protein (Fig. 5c–e and Supplementary Fig. 9a).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > β-cell PDGFR controls Ezh2 via Erk and Rb/E2f
What the sources say
- Not checked yetcites [24] Uhrbom, L., Nerio, E. & Holland, E. C. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. Nature Med. 10, 1257–1260 (2004) source
- Not checked yetcites [25] Furstoss, O., Manes, G. & Roche, S. Cyclin E and cyclin A are likely targets of Src for PDGF-induced DNA synthesis in fibroblasts. FEBS Lett. 526, 82–86 (2002) source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Islet ChIP studies revealed increased E2f1 association, and reduced E2f4 association with Ezh2 cis-regulatory elements (Supplementary Fig. 12d, e).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > β-cell PDGFR controls Ezh2 via Erk and Rb/E2f
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Ezh2 induction in juvenile wild-type islets exposed to PDGF-AA was blocked by U0126, which inhibits Erk1/2 activation23, but not by LY294002 or U-73122, inhibitors of PI3K or PLC-γ signalling (Supplementary Fig. 8a).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > β-cell PDGFR controls Ezh2 via Erk and Rb/E2f
What the sources say
- Not checked yetcites [23] Duncia, J. V. et al. MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg. Med. Chem. Lett. 8, 2839–2844 (1998) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“To assess whether premature Pdgfr loss might compromise Ezh2-dependent neonatal β-cell proliferation, we generated RIP-Cre; Pdgfraf/f mice (abbreviated to βPdgfrαKO) that permit conditional Pdgfra inactivation in islet β-cells and loss of detectable Pdgfra mRNA and protein expression (Fig. 1d and Supplementary Fig. 3a).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Age-dependent β-cell Pdgfr-α loss
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As expected, β-cell BrdU incorporation and mass were increased in βEzh2HET-RαTg mice (Fig. 4c, d and Supplementary Fig. 7) compared to controls (either Ezh2f/f, R26-PDGFRαD842V or Ezh2f/+, R26-PDGFRαD842V genotype).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF-induced β-cell expansion requires Ezh2
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consistent with this view, β-cell mass in control mice gradually recovered after STZ treatment, accompanied by increased β-cell Ezh2 expression and proliferation; in contrast, βPdgfαKO β-cells failed to increase Ezh2 or proliferation to restore β-cell mass (Fig. 2c–e).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Pdgfr-α controls adult β-cell regeneration
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also detected increased phosphorylation of Erk1/2, but not phosphorylation of Akt or PLC-γ, in βPDGFRαTg islets compared to control islets (Fig. 5a, b).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > β-cell PDGFR controls Ezh2 via Erk and Rb/E2f
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast to littermate controls, mice with the RIP-Cre; R26-PDGFRAD842V genotype (abbreviated to βPDGFRαTg) expressed human PDGFRA mRNA and PDGFR-a(D842V) protein in islet β-cells (Fig. 3a and Supplementary Fig. 5a).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGFR-α promotes functional β-cell expansion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ChIP studies also revealed that association of E2f1 with Ezh2 decreased, whereas association of E2f4 with Ezh2 elements increased in islets with age (Supplementary Fig. 11c, d).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > β-cell PDGFR controls Ezh2 via Erk and Rb/E2f
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By 3 months, β-cell Ezh2 expression had declined in control mice, but β-cell Ezh2 expression in βPDGFRαTg mice was maintained at elevated levels, a difference that persisted for 8–14 months (Fig. 3e, f).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGFR-α promotes functional β-cell expansion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similarly, increased β-cell BrdU incorporation in islets exposed to PDGF-AA was blocked by U0126, but not by LY294002 (Supplementary Fig. 8b), indicating that Erk mediates β-cell Pdgf signalling responses.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > β-cell PDGFR controls Ezh2 via Erk and Rb/E2f
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We identified two conserved candidate E2f-binding elements near the Ezh2 promoter (Supplementary Fig. 10), and chromatin immunoprecipitation (ChIP) studies showed increased E2f1 association and reduced E2f4 association with these Ezh2 elements in βPDGFRαTg islets (Fig. 5f, g).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > β-cell PDGFR controls Ezh2 via Erk and Rb/E2f
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Exposure of 3-week-old islets to PDGF-AA increased phospho-Pdgfr-α levels and Ezh2 mRNA and protein levels, but not Ezh1 expression (Supplementary Fig. 4a–c).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGFR-α promotes functional β-cell expansion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By contrast, increased islet Ezh2 mRNA levels and β-cell Ezh2 protein were not observed in βEzh2KO-RαTg or βEzh2KO littermates (Fig. 4b and Supplementary Fig. 7), confirming Cre-mediated deletion of Ezh2 in these mice.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF-induced β-cell expansion requires Ezh2
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared to controls, β-cell Ezh2 protein and islet Ezh2 mRNA levels were reduced whereas p16INK4a mRNA levels were increased in βPdgfrαKO islets (Fig. 1e and Supplementary Fig. 3a, b); in contrast, Pdgfrb and Ezh1 mRNA levels were unchanged in βPdgfrαKO islets (Supplementary Fig. 3c, d).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Age-dependent β-cell Pdgfr-α loss
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During re-feeding after overnight fast, βPDGFRαTg mice had a 25% reduction of blood glucose (Fig. 3g), associated with a modest elevation of plasma insulin levels (Supplementary Fig. 6i), and both changes were sustained for up to 14 months.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGFR-α promotes functional β-cell expansion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Expression of R26-PDGFRαD842V did not affect endogenous islet Pdgfra mRNA levels (Fig. 3a) or β-cell expansion and glucose control in neonatal or juvenile βPDGFRαTg mice (Fig. 3b, c and Supplementary Figs 5b and 6a–d).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGFR-α promotes functional β-cell expansion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“β-cell mass was increased in βPDGFRαTg mice at 3 months, and remained increased at 14 months compared to age-matched controls (Fig. 3b).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGFR-α promotes functional β-cell expansion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consistent with these findings, we detected modest postprandial blood glucose reduction and increased blood insulin levels in βEzh2HET-RαTg mice, but not in βEzh2KO-RαTg mice (Fig. 4e, f).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF-induced β-cell expansion requires Ezh2
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, control mice became moderately diabetic immediately after STZ challenge, but achieved restored glucose control 3–4 weeks thereafter (Fig. 2f), coinciding with increases of β-cell mass (Fig. 2e).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Pdgfr-α controls adult β-cell regeneration
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, loss of β-cell Pdgf signalling in βPdgfαKO mice diminished islet levels of Ccnd1 mRNA, and reduced numbers of phospho-Erk1/2+ and phospho-Rb+ β-cells (Supplementary Fig. 9b, c).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > β-cell PDGFR controls Ezh2 via Erk and Rb/E2f
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared to controls, β-cell Ezh2 protein and islet Ezh2 mRNA levels were reduced whereas p16INK4a mRNA levels were increased in βPdgfrαKO islets (Fig. 1e and Supplementary Fig. 3a, b); in contrast, Pdgfrb and Ezh1 mRNA levels were unchanged in βPdgfrαKO islets (Supplementary Fig. 3c, d).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Age-dependent β-cell Pdgfr-α loss
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, basal EZH2 mRNA levels were lower in adult islets and not induced by PDGF-AA (Fig. 6c).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF control of human β-cell proliferation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“mRNA levels of EZH2, but not EZH1, were increased in juvenile human islets exposed to PDGF-AA, an effect blocked by Sunitinib or U0126 (Fig. 6c and Supplementary Fig. 13a).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF control of human β-cell proliferation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, PDGFR-a was only detected in non-β-cells of islets from adult human donors, with little to no detectable phospho-ERK1/2, phospho-RB or EZH2 in β-cells (Fig. 6a, b), suggesting that PDGF signalling attenuation is a conserved feature of ageing islet β-cells.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF control of human β-cell proliferation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“RbTriKO mice became hypoglycaemic and developed other islet and metabolic phenotypes reminiscent of insulinoma pathogenesis.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similar to juvenile mouse islets with activated Pdgf signalling, ChIP studies demonstrated PDGF-AA-stimulated association of E2F1 with the human EZH2 locus, an effect blocked by Sunitinib (Fig. 6d).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF control of human β-cell proliferation
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared to vehicle-exposed controls, juvenile islets exposed to PDGF-AA had a sixfold increase of β-cell BrdU incorporation, an effect eliminated by simultaneous exposure to Sunitinib or U0126 (Fig. 6e, f).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF control of human β-cell proliferation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Like in juvenile mice, PDGFR-α protein and phospho-ERK1/2 levels were readily detected in islets from young human donors (Fig. 6a, b).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF control of human β-cell proliferation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Proliferating BrdU+ cells in juvenile islets stimulated by PDGF-AA were predominantly β-cells, verified by immuno-localization of BrdU+ nuclei within insulin+ cells and PDX1+ nuclei with confocal microscopy (Fig. 6f and Supplementary Fig. 13b, c).”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGF control of human β-cell proliferation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, pathological loss of all Rb family proteins in RbTriKO islets led to a fourfold increase in Ezh2 mRNA, and a 15-fold increase in β-cell proliferation.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Ezh2 is a histone methyltransferase crucial for trimethylation of histone H3 on Lys 27 (H3K27me3), a modification mediating transcriptional repression14,15.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
What the sources say
- Not checked yetcites [14] Cao, R. et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039–1043 (2002) source
- Not checked yetcites [15] van der Vlag, J. & Otte, A. P. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nature Genet. 23, 474–478 (1999) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Likewise, induction of human islet β-cell proliferation remains an unattained goal, with studies reporting inconsistent mitogenic responses5,6.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“We showed that the polycomb group protein Ezh2 represses Cdkn2a and promotes β-cell proliferation in juvenile mouse islets13.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
What the sources say
- Not checked yetcites [13] Chen, H. et al. Polycomb protein Ezh2 regulates pancreatic β-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 23, 975–985 (2009) source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In mice or other experimental animals, β-cell expansion from such efforts has been transient or limited, and often complicated by uncontrolled β-cell growth, loss of defining β-cell features and impaired metabolic control3,4.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
What the sources say
- Not checked yetcites [3] Vasavada, R. C. et al. Targeted expression of placental lactogen in the β-cells of transgenic mice results in β-cell proliferation, islet mass augmentation, and hypoglycemia. J. Biol. Chem. 275, 15399–15406 (2000) source
- Not checked yetcites [4] Garcia-Ocana, A. et al. Hepatocyte growth factor overexpression in the islet of transgenic mice increases β-cell proliferation, enhances islet mass, and induces mild hypoglycemia. J. Biol. Chem. 275, 1226–1232 (2000) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Pancreatic β-cell proliferation decreases rapidly in juvenile mice and humans, then declines more slowly in adults9,10.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
What the sources say
- Not checked yetcites [9] Teta, M. et al. Very slow turnover of β-cells in aged adult mice. Diabetes 54, 2557–2567 (2005) source
- Not checked yetcites [10] Meier, J. J. et al. β-Cell replication is the primary mechanism subserving the postnatal expansion of β-cell mass in humans. Diabetes 57, 1584–1594 (2008) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, premature loss of Pdgfra impairs β-cell proliferation and expansion and glucose control in young mice.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Age-dependent β-cell Pdgfr-α loss
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Modulation of β-cell Pdgf signalling attenuates age-dependent proliferative failure and Ezh2 loss, permitting in vivo expansion of β-cells with regulated function.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Pdgfr signalling promotes proliferation, survival and migration in diverse cell types16.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
What the sources say
- Not checked yetcites [16] Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 103, 211–225 (2000) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Pdgf-induced actin polymerization in fibroblasts requires Ezh2 (ref. 19), suggesting that Pdgf signalling might regulate Ezh2 expression and age-dependent β-cell proliferation in islets.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
What the sources say
- Not checked yetcites [19] Su, I. et al. Polycomb group protein Ezh2 controls actin polymerization and cell signaling. Cell 121, 425–436 (2005) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, age-dependent attenuation of β-cell Pdgfr-α altered Erk and Rb/E2f signalling, resulting in reduced Ezh2 expression.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > β-cell PDGFR controls Ezh2 via Erk and Rb/E2f
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, PDGF-AA exposure was sufficient to stimulate β-cell replication in juvenile islets, but loss of competence for Pdgf prevented this response to PDGF-AA in adult islets.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGFR-α promotes functional β-cell expansion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, PDGFRaTg mice maintained normal glucose-regulated insulin release and glycaemic control, suggesting that β-cell function remained regulated in these mice.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > PDGFR-α promotes functional β-cell expansion
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cardinal features of this pathway are conserved in human islets, permitting conditional induction of human β-cell replication.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, the molecular basis for these observations and the roles of Pdgf signalling in islet β-cell growth and development were not established17,18,32.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
What the sources say
- Not checked yetcites [17] Swenne, I. et al. Effects of platelet-derived growth factor and somatomedin-C/insulin-like growth factor I on the deoxyribonucleic acid replication of fetal rat islets of Langerhans in tissue culture. Endocrinology 122, 214–218 (1988) source
- Not checked yetcites [18] Welsh, M. et al. Coexpression of the platelet-derived growth factor (PDGF) B chain and the PDGF beta receptor in isolated pancreatic islet cells stimulates DNA synthesis. Proc. Natl Acad. Sci. USA 87, 5807–5811 (1990) source
- Not checked yetcites [32] LeBras, S., Czernichow, P. & Scharfmann, R. A search for tyrosine kinase receptors expressed in the rat embryonic pancreas. Diabetologia 41, 1474–1481 (1998) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
In the paper
“Proliferative responses to PDGF decline in some ageing cells30, and progenitor cell self-renewal is impaired by Pdgf signalling disruption31.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
What the sources say
- Not checked yetcites [30] Scherping, S. C., Jr et al. Effect of growth factors on the proliferation of ligament fibroblasts from skeletally mature rabbits. Connect. Tissue Res. 36, 1–8 (1997) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Institutional review board approval for research use of tissue was obtained from Stanford University School of Medicine.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > METHODS > Human pancreas and islet studies
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Our work also suggests that Mapk/Erk regulation links Pdgfr activation to Ezh2 induction and β-cell proliferation, consistent with studies demonstrating Erk regulation of Ezh2 in cancer cells33, and Erk activation that accompanies mouse β-cell expansion in pregnancy34.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
What the sources say
- Not checked yetcites [33] Fujii, S. et al. MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes. Oncogene 10.1038/onc.2011.118 (18 April 2011) source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“MIP-GFP+ β-cells with >95% purity were harvested and immediately lysed for RNA purification and real-time RT–PCR analysis.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > METHODS > β-cell purification by FACS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that β-cell Pdgfr signalling was required for Ezh2 induction, to sustain both physiological and regenerative β-cell proliferation.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, Rb proteins constrain Ezh2 expression and adult islet cell growth.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > β-cell PDGFR controls Ezh2 via Erk and Rb/E2f
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“PDGF ligands are measurable in serum, and regulation of such circulating signalling agonists may provide an additional level of growth control in competent islet β-cells.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Human pancreases or islets from organ donors were procured by arrangement with the National Disease Resource Interchange and the University of Alabama, Birmingham with appropriate consent.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > METHODS > Human pancreas and islet studies
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“Although the mechanisms underlying pancreatic β-cell expansion in physiological settings may differ between species36,37, age-dependent restriction of β-cell proliferation is a conserved feature in mice and humans9,10.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
What the sources say
- Not checked yetcites [36] Butler, A. E. et al. Adaptive changes in pancreatic β-cell fractional area and β-cell turnover in human pregnancy. Diabetologia 53, 2167–2176 (2010) source
- Not checked yetcites [37] Rieck, S. & Kaestner, K. H. Expansion of β-cell mass in response to pregnancy. Trends Endocrinol. Metab. 21, 151–158 (2010) source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Our work also suggests that Mapk/Erk regulation links Pdgfr activation to Ezh2 induction and β-cell proliferation, consistent with studies demonstrating Erk regulation of Ezh2 in cancer cells33, and Erk activation that accompanies mouse β-cell expansion in pregnancy34.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
What the sources say
- Not checked yetcites [34] Gupta, R. K. et al. Expansion of adult β-cell mass in response to increased metabolic demand is dependent on HNF-4α. Genes Dev. 21, 756–769 (2007) source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Prior studies correlated increased PDGFR and EZH2 expression in human endocrine neoplasias38, and disrupted PDGF signalling in β-cells of humans with type 2 diabetes39.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
What the sources say
- Not checked yetcites [38] Ebert, M. et al. Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int. J. Cancer 62, 529–535 (1995) source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All animal experiments and methods were approved by the Institutional Animal Care and Use Committee of Stanford University.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > METHODS > Animals
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Experiments were repeated onmultiple pancreas sections for every donor pancreas and similar results were obtained.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > METHODS > Human pancreas and islet studies
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Proliferative responses to PDGF decline in some ageing cells30, and progenitor cell self-renewal is impaired by Pdgf signalling disruption31.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
What the sources say
- Not checked yetcites [31] Pallante, B. A. et al. Bone marrow Oct3/4+ cells differentiate into cardiac myocytes via age-dependent paracrine mechanisms. Circ. Res. 100, e1–e11 (2007) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Mice used in this study were age- and gender-matched littermates including both sexes.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > METHODS > Animals
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, our demonstration that PDGF signalling regulates EZH2,CDKN2A and β-cell proliferation in human islets combines several observations into a new molecular model for physiological and pathological β-cell growth.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Images were analysed with an ImagePro program by observers blinded to genotype, and pancreatic β-cell mass and percentage of BrdU+ β-cells were calculated as described previously13.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > METHODS > Histology, immunofluorescence and immunohistochemistry
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In vivo activation of β-cell PDGFR-α signalling increased Ezh2 expression and mitigated age-dependent decline of β-cell proliferation.”
§ PDGF signalling controls age-dependent proliferation in pancreatic β-cells > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such a mechanism has been shown recently to operate in the pancreas, where PDGF regulates the levels of Ink4a in pancreatic  cells.42”
From Fibroblast growth factor-7 partially reverses murine thymocyte progenitor aging by repression of Ink4a (2012) · cites this paper as [42]
In the citing paper
“A key tenet of the model shown in Figure 6 is that exogenous factors in the microenvironment can affect the senescent state of target cells by regulating gene expression in them.”
From Fibroblast growth factor-7 partially reverses murine thymocyte progenitor aging by repression of Ink4a (2012) · cites this paper as [42]
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
Dor, Y., Brown, J., Martinez, O. I., & Melton, D. A. (2004) · Nature · doi:10.1038/nature02520 · Cited by 2,219
Mendel, D. B., Laird, A., Xin, X., Louie, S. G., Christensen, J. G., Li, G., Schreck, R., Abrams, T. J., Ngai, T. J., Lee, L. B., et al. (2003) · PubMed · Cited by 1,956
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg542 · Cited by 1,196
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Hilberg, F., Roth, G. J., Krssak, M., Kautschitsch, S., Sommergruber, W., Tontsch-Grunt, U., Garin-Chesa, P., Bader, G., Zoephel, A., Quant, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6307 · Cited by 1,056
p16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003
Meier, J. J., Butler, A. E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., Rizza, R. A., & Butler, P. C. (2008) · Diabetes · doi:10.2337/db07-1369 · Cited by 683
Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages
Herrera, P. L. (2000) · Development · doi:10.1242/dev.127.11.2317 · Cited by 674
Cited by
Sorted by citations
DNA methylation-based biomarkers and the epigenetic clock theory of ageing
Horvath, S., & Raj, K. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0004-3 · Cited by 3,095
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Senescence in Health and Disease
He, S., & Sharpless, N. E. (2017) · Cell · doi:10.1016/j.cell.2017.05.015 · Cited by 1,766
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104
Enge, M., Arda, H. E., Mignardi, M., Beausang, J., Bottino, R., Kim, S. K., & Quake, S. R. (2017) · Cell · doi:10.1016/j.cell.2017.09.004 · Cited by 568
Self-citationMonitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model
Burd, C. E., Sorrentino, J. A., Clark, K. S., Darr, D. B., Krishnamurthy, J., Deal, A. M., Bardeesy, N., Castrillon, D. H., Beach, D. H., & Sharpless, N. E. (2013) · Cell · doi:10.1016/j.cell.2012.12.010 · Cited by 419
Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers
Chera, S., Baronnier, D., Ghila, L., Cigliola, V., Jensen, J. N., Gu, G., Furuyama, K., Thorel, F., Gribble, F. M., Reimann, F., et al. (2014) · Nature · doi:10.1038/nature13633 · Cited by 410
The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities
Ying, W., Fu, W., Lee, Y. S., & Olefsky, J. M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0286-3 · Cited by 410
A Systems Genetics Approach Identifies Genes and Pathways for Type 2 Diabetes in Human Islets
Taneera, J., Lang, S., Sharma, A., Fadista, J., Zhou, Y., Ahlqvist, E., Jonsson, A. E., Lyssenko, V., Vikman, P. J., Hansson, O., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.006 · Cited by 386
The Molecular Balancing Act of p16INK4a in Cancer and Aging
LaPak, K. M., & Burd, C. E. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0350 · Cited by 304
Effect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients With Breast Cancer
Sanoff, H. K., Deal, A. M., Krishnamurthy, J., Torrice, C., Dillon, P., Sorrentino, J., Ibrahim, J. G., Jolly, T. A., Williams, G., Carey, L. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju057 · Cited by 283
Ying, W., Lee, Y. S., Dong, Y. W., Seidman, J. S., Yang, M., Isaac, R., Seo, J. B., Yang, B.-H., Wollam, J., Riopel, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.003 · Cited by 281
Pancreatic β Cell Regeneration as a Possible Therapy for Diabetes
Aguayo‐Mazzucato, C., & Bonner‐Weir, S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.007 · Cited by 247
Human β-Cell Proliferation and Intracellular Signaling
Kulkarni, R., Mizrachi, E.-B., Garcı́a-Ocaña, A., & Stewart, A. F. (2012) · Diabetes · doi:10.2337/db12-0018 · Cited by 243
Age-Dependent Pancreatic Gene Regulation Reveals Mechanisms Governing Human β Cell Function
Arda, H. E., Li, L., Tsai, J., Torre, E. A., Rosli, Y., Peiris, H., Spitale, R. C., Dai, C., Gu, X., Qu, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.002 · Cited by 222
Self-citationConverting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx
Chakravarthy, H., Gu, X., Enge, M., Dai, X.-Q., Wang, Y., Damond, N., Downie, C. G., Liu, K., Wang, J., Xing, Y., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.01.009 · Cited by 215
Self-citationBRD4 is a novel therapeutic target for liver fibrosis
Ding, N., Hah, N., Yu, R. T., Sherman, M. H., Benner, C., Leblanc, M., He, M., Liddle, C., Downes, M., & Evans, R. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522163112 · Cited by 211
Diabetes mellitus—advances and challenges in human β-cell proliferation
Wang, P., Fiaschi‐Taesch, N., Vasavada, R. C., Scott, D. K., García-Ocaña, A., & Stewart, A. F. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.9 · Cited by 210
Review: a meta‐analysis of GWAS and age‐associated diseases
Jeck, W. R., Siebold, A. P., & Sharpless, N. E. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00871.x · Cited by 204
The Pericyte of the Pancreatic Islet Regulates Capillary Diameter and Local Blood Flow
Almaça, J., Weitz, J., Rodriguez‐Diaz, R., Pereira, E., & Caicedo, A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.016 · Cited by 200
MicroRNA-7 Regulates the mTOR Pathway and Proliferation in Adult Pancreatic β-Cells
Wang, Y., Liu, J., Liu, C., Naji, A., & Stoffers, D. A. (2012) · Diabetes · doi:10.2337/db12-0451 · Cited by 196
Coming of age: molecular drivers of aging and therapeutic opportunities
Newgard, C. B., & Sharpless, N. E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68833 · Cited by 194
Yoshihara, E., Wei, Z., Lin, C. S., Fang, S., Ahmadian, M., Kida, Y. S., Tseng, T. W., Dai, Y. D., Yu, R. T., Liddle, C., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.005 · Cited by 183
Heldin, C., & Lennartsson, J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009100 · Cited by 171
Bernal‐Mizrachi, E., Kulkarni, R., Scott, D. K., Mauvais‐Jarvis, F., Stewart, A. F., & Garcı́a-Ocaña, A. (2014) · Diabetes · doi:10.2337/db13-1146 · Cited by 172
The Beta Cell in Type 2 Diabetes
Christensen, A. A., & GANNON, M. A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1196-4 · Cited by 170
Gene Regulatory Networks Governing Pancreas Development
Arda, H. E., Benitez, C. M., & Kim, S. K. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.03.016 · Cited by 163
Self-citationSingle-Cell Mass Cytometry Analysis of the Human Endocrine Pancreas
Wang, Y. J., Golson, M. L., Schug, J., Traum, D., Liu, C., Vivek, K., Dorrell, C., Naji, A., Powers, A. C., Chang, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.007 · Cited by 157
Wang, P., Karakose, E., Liu, H., Swartz, E., Ackeifi, C., Zlatanic, V., Wilson, J., González, B. J., Bender, A., Takane, K. K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.005 · Cited by 162
The role of aging upon β cell turnover
Kushner, J. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64095 · Cited by 167
MicroRNAs as stress regulators in pancreatic beta cells and diabetes
LaPierre, M. P., & Stoffel, M. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.020 · Cited by 160
Signals in the pancreatic islet microenvironment influence β‐cell proliferation
Aamodt, K. I., & Powers, A. C. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13031 · Cited by 166
Dai, C., Hang, Y., Shostak, A., Poffenberger, G., Hart, N. J., Prasad, N., Phillips, N., Levy, S., Greiner, D. L., Shultz, L. D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91761 · Cited by 148
Self-citationPseudotemporal Ordering of Single Cells Reveals Metabolic Control of Postnatal β Cell Proliferation
Zeng, C., Mulas, F., Sui, Y., Guan, T., Miller, N., Tan, Y., Liu, F., Jin, W. L., Carrano, A. C., Huising, M. O., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.014 · Cited by 141
Human β-Cell Proliferation and Intracellular Signaling: Part 3
Stewart, A. F., Hussain, M. A., García-Ocaña, A., Vasavada, R. C., Bhushan, A., Bernal-Mizrachi, E., & Kulkarni, R. N. (2015) · Diabetes · doi:10.2337/db14-1843 · Cited by 142
Age-Related Impairment of Pancreatic Beta-Cell Function: Pathophysiological and Cellular Mechanisms
Tata, V. D. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00138 · Cited by 157
Farahani, R. H., & Xaymardan, M. (2015) · Stem Cells International · doi:10.1155/2015/362753 · Cited by 145
Li, Y., Shen, Y., Hohensinner, P. J., Ju, J., Wen, Z., Goodman, S. B., Zhang, H., Goronzy, J. J., & Weyand, C. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.013 · Cited by 138
Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states
El Ouaamari, A., Kawamori, D., Dirice, E., Liew, C. W., Shadrach, J. L., Hu, J., Katsuta, H., Hollister-Lock, J., Qian, W.-J., Wagers, A. J., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.007 · Cited by 136
Skin Adipocyte Stem Cell Self-Renewal Is Regulated by a PDGFA/AKT-Signaling Axis
Rivera-Gonzalez, G. C., Shook, B. A., Andræ, J., Holtrup, B., Bollag, K., Betsholtz, C., Rodeheffer, M. S., & Horsley, V. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.09.002 · Cited by 135
When less is more: the forbidden fruits of gene repression in the adult β‐cell
Pullen, T. J., & Rutter, G. A. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12029 · Cited by 127
Systemic Regulation of the Age-Related Decline of Pancreatic β-Cell Replication
Salpeter, S. J., Khalaileh, A., Weinberg-Corem, N., Ziv, O., Glaser, B., & Dor, Y. (2013) · Diabetes · doi:10.2337/db13-0160 · Cited by 122
Inhibition of TGF-β Signaling Promotes Human Pancreatic β-Cell Replication
Dhawan, S., Dirice, E., Kulkarni, R. N., & Bhushan, A. (2016) · Diabetes · doi:10.2337/db15-1331 · Cited by 119
Gharibi, B., Ghuman, M. S., & Hughes, F. J. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01602.x · Cited by 118
Jacovetti, C., Matkovich, S. J., Rodriguez‐Trejo, A., Guay, C., & Regazzi, R. (2015) · Nature Communications · doi:10.1038/ncomms9084 · Cited by 111
Han, J., Mistriotis, P., Lei, P., Wang, D., Liu, S., & Andreadis, S. T. (2012) · Stem Cells · doi:10.1002/stem.1223 · Cited by 106
Differential impact of RB status on E2F1 reprogramming in human cancer
McNair, C. M., Xu, K., Mandigo, A. C., Benelli, M., Leiby, B. E., Rodrigues, D. N., Lindberg, J., Grönberg, H., Crespo, M., Laere, B. D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93566 · Cited by 104
PDGF and the progression of renal disease
Boor, P., Ostendorf, T., & Floege, J. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft273 · Cited by 99
Raptor regulates functional maturation of murine beta cells
Ni, Q., Gu, Y., Xie, Y., Yin, Q., Zhang, H., Nie, A., Li, W., Wang, Y., Ning, G., Wang, W., et al. (2017) · Nature Communications · doi:10.1038/ncomms15755 · Cited by 94
Nkx6.1 regulates islet β-cell proliferation via Nr4a1 and Nr4a3 nuclear receptors
Tessem, J. S., Moss, L. G., Chao, L. C., Arlotto, M. E., Lu, D., Jensen, M. V., Stephens, S. B., Tontonoz, P., Hohmeier, H. E., & Newgard, C. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320953111 · Cited by 98
Localization of adaptive variants in human genomes using averaged one-dependence estimation
Sugden, L. A., Atkinson, E. G., Fischer, A. P., Rong, S., Henn, B. M., & Ramachandran, S. (2018) · Nature Communications · doi:10.1038/s41467-018-03100-7 · Cited by 91
MANF protects human pancreatic beta cells against stress-induced cell death
Hakonen, E. T., Chandra, V., Fogarty, C. L., Yu, N., Ustinov, J., Katayama, S., Galli, E., Danilova, T., Lindholm, P., Vartiainen, A., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4687-y · Cited by 88
Vascular aging: implications for cardiovascular disease and therapy
Ghebre, Y. T., Yakubov, E., Wong, W. T., & Krishnamurthy, P. (2016) · Translational Medicine · doi:10.4172/2161-1025.1000183 · Cited by 87
Disallowed and Allowed Gene Expression: Two Faces of Mature Islet Beta Cells
Lemaire, K., Thorrez, L., & Schuit, F. C. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050808 · Cited by 86
Pregnancy‐induced changes in β‐cell function: what are the key players?
Salazar‐Petres, E., & Sferruzzi-Perri, A. N. (2021) · The Journal of Physiology · doi:10.1113/jp281082 · Cited by 91
β cell aging and age-related diabetes
Zhu, M., Liu, X., Liu, W., Lu, Y., Cheng, J., & Chen, Y. (2021) · Aging · doi:10.18632/aging.202593 · Cited by 96
p16INK4a reporter mice reveal age-promoting effects of environmental toxicants
Sorrentino, J. A., Krishnamurthy, J., Tilley, S. L., Alb, J. G., Burd, C. E., & Sharpless, N. E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70960 · Cited by 85
Schuit, F. C., Lommel, L. V., Granvik, M., Goyvaerts, L., de Faudeur, G., Schraenen, A., & Lemaire, K. (2012) · Diabetes · doi:10.2337/db11-1564 · Cited by 82
Effects of ageing and senescence on pancreatic β‐cell function
Helman, A., Avrahami, D., Klochendler, A., Gläser, B., Kaestner, K. H., Ben‐Porath, I., & Dor, Y. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12719 · Cited by 83
PDGFR-β Signaling Regulates Cardiomyocyte Proliferation and Myocardial Regeneration
Zhang, Y., Chen, J., Lian, H., Pei, J., Li, Y., Chen, X., Song, S., Xia, J., Zhou, B., Feng, J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.065 · Cited by 80
Ageing as developmental decay: insights from p16INK4a.
Martin, N., Beach, D., & Gil, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.008 · Cited by 76
The pancreatic β-cell in ageing: Implications in age-related diabetes
Tudurí, E., Soriano, S., Almagro, L., Montanya, E., Alonso‐Magdalena, P., Nadal, Á., & Quesada, I. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101674 · Cited by 93
Riley, K. G., Pasek, R. C., Maulis, M. F., Peek, J. L., Thorel, F., Brigstock, D. R., Herrera, P. L., & GANNON, M. A. (2014) · Diabetes · doi:10.2337/db14-1195 · Cited by 70
Human Pancreatic β-Cell G1/S Molecule Cell Cycle Atlas
Fiaschi‐Taesch, N., Kleinberger, J. W., Salim, F. G., Troxell, R., Wills, R. C., Tanwir, M., Casinelli, G. P., Cox, A. E., Takane, K. K., Scott, D. K., et al. (2013) · Diabetes · doi:10.2337/db12-0777 · Cited by 69
Garfin, P. M., Min, D., Bryson, J. L., Serwold, T. F., Edris, B., Blackburn, C. C., Richie, E. R., Weinberg, K. I., Manley, N. R., Sage, J., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121716 · Cited by 69
Self-citationAll mixed up: defining roles for β-cell subtypes in mature isletsPreprint
Liu, J. S. E., & Hebrok, M. (2017) · Genes & Development · doi:10.1101/gad.294389.116 · Cited by 68
Pancreatic Beta Cells in Very Old Mice Retain Capacity for Compensatory Proliferation
Stolovich-Rain, M., Hija, A., Grimsby, J. S., Gläser, B., & Dor, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350736 · Cited by 70
Defining the toxicology of aging
Sorrentino, J. A., Sanoff, H. K., & Sharpless, N. E. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.04.004 · Cited by 69
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure
Son, J., Du, W. J., Esposito, M., Shariati, K., Ding, H., Kang, Y., & Accili, D. (2023) · Nature Communications · doi:10.1038/s41467-023-36315-4 · Cited by 67
Zhang, P., Garnett, J., Creighton, C. J., Sannaa, G. A. A., Igram, D. R., Lazar, A. J., Liu, X., Liu, C., & Pollock, R. E. (2013) · The Journal of Pathology · doi:10.1002/path.4294 · Cited by 63
Ji, Y., Sun, S., Shrestha, N., Darragh, L. B., Shirakawa, J., Xing, Y., He, Y., Carboneau, L., Kim, H., An, D., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0396-z · Cited by 64
miRNA‐34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA
Wang, P., Xu, J., Hou, Z.-L., Wang, F., Song, Y., Wang, J., Zhu, H. F., & Jin, H. (2016) · Cell Proliferation · doi:10.1111/cpr.12265 · Cited by 62
Self-citationAdvances in β cell replacement and regeneration strategies for treating diabetes
Benthuysen, J. R., Carrano, A. C., & Sander, M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87439 · Cited by 68
miR-184 Regulates Pancreatic β-Cell Function According to Glucose Metabolism
Tattikota, S. G., Rathjen, T., Hausser, J., Khedkar, A., Kabra, U. D., Pandey, V., Sury, M. D., Wessels, H., Mollet, I. G., Eliasson, L., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658625 · Cited by 59
Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases
Heldin, C. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9484-2 · Cited by 64
MiRNAs in β-Cell Development, Identity, and Disease
Martínez-Sánchez, A., Rutter, G. A., & Latreille, M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2016.00226 · Cited by 63
Activation of Platelet-Derived Growth Factor Receptor Alpha Contributes to Liver Fibrosis
Hayes, B. J., Riehle, K. J., Shimizu-Albergine, M., Bauer, R. L., Hudkins, K. L., Johansson, F., Yeh, M. M., Mahoney, W. M., Yeung, R. S., & Campbell, J. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092925 · Cited by 59
Chen, H., Kleinberger, J. W., Takane, K. K., Salim, F. G., Fiaschi‐Taesch, N., Pappas, K., Parsons, R. E., Jiang, J., Zhang, Y., Liu, H., et al. (2015) · Diabetes · doi:10.2337/db15-0083 · Cited by 59
Self-citationPullen, T. J., Huising, M. O., & Rutter, G. A. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00041 · Cited by 57
Ye, W., Ni, Z., Yicheng, S., Pan, H., Huang, Y., Xiong, Y., & Liu, T. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4887 · Cited by 59
Combined modulation of polycomb and trithorax genes rejuvenates β cell replication
Zhou, J. X., Dhawan, S., Fu, H., Snyder, E., Bottino, R., Kundu, S., Kim, S. K., & Bhushan, A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69468 · Cited by 59
Self-citationCytoplasmic-Nuclear Trafficking of G1/S Cell Cycle Molecules and Adult Human β-Cell Replication
Fiaschi‐Taesch, N., Kleinberger, J. W., Salim, F. G., Troxell, R., Wills, R. C., Tanwir, M., Casinelli, G. P., Cox, A. E., Takane, K. K., Srinivas, H., et al. (2013) · Diabetes · doi:10.2337/db12-0778 · Cited by 59
Aging and stress induced β cell senescence and its implication in diabetes development
Li, N., Liu, F., Yang, P. C., Xiong, F., Yu, Q., Li, J., Zhou, Z., Zhang, S., & Wang, C. (2019) · Aging · doi:10.18632/aging.102432 · Cited by 64
The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes
Hill, T., Krougly, O., Nikoopour, E., Bellemore, S. M., Lee‐Chan, E., Fouser, L. A., Hill, D. J., & Singh, B. (2013) · Cell Regeneration · doi:10.1186/2045-9769-2-2 · Cited by 55
Wisp1 is a circulating factor that stimulates proliferation of adult mouse and human beta cells
Fernandez‐Ruiz, R., García, A., Esteban, Y., Mir-Coll, J., Serra-Navarro, B., Fontcuberta-PiSunyer, M., Broca, C., Armanet, M., Wojtusciszyn, A., Kram, V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19657-1 · Cited by 57
Chen, J., Lippo, L., Labella, R., Tan, S. L., Marsden, B. D., Dustin, M. L., Ramasamy, S. K., & Kusumbe, A. P. (2020) · The EMBO Journal · doi:10.15252/embj.2020105242 · Cited by 58
Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges
Wang, P., Karaköse, E., Choleva, L., Kumar, K., DeVita, R. J., García-Ocaña, A., & Stewart, A. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.671946 · Cited by 54
The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations
Ardestani, A. D., & Maedler, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00167 · Cited by 57
The supply chain of human pancreatic β cell lines
Scharfmann, R., Staels, W., & Albagli, O. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129484 · Cited by 54
Shaping Pancreatic β-Cell Differentiation and Functioning: The Influence of Mechanotransduction
Galli, A., Marku, A., Marciani, P., Schulte, C., Lenardi, C., Paolo, M., Maffioli, E., Tedeschi, G., & Perego, C. (2020) · Cells · doi:10.3390/cells9020413 · Cited by 51
Role of microRNAs in the age-associated decline of pancreatic beta cell function in rat islets
Tugay, K., Guay, C., Marques, A. C., Allagnat, F., Locke, J. M., Harries, L. W., Rutter, G. A., & Regazzi, R. (2015) · Diabetologia · doi:10.1007/s00125-015-3783-5 · Cited by 51
Sandovici, I., Hammerle, C. M., Ozanne, S. E., & Constância, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1297-1 · Cited by 52
Inflammatory signaling pathways in pancreatic β-cell: New insights into type 2 diabetes pathogenesis
Chen, J., Fei, S., Chan, L., Gan, X., Shao, B., Jiang, H., Li, S., Kuang, P., Liu, X., & Yang, S. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107776 · Cited by 50
Epigenetic modifications and long noncoding RNAs influence pancreas development and function
Arnes, L., & Sussel, L. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.02.008 · Cited by 54
FOXA1 mediates p16INK4a activation during cellular senescence
Li, Q., Zhang, Y., Fu, J., Han, L., Xue, L., Lv, C., Wang, P., Li, G., & Tong, T. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.35 · Cited by 50
PTEN controls β‐cell regeneration in aged mice by regulating cell cycle inhibitor p16 ink4a
Zeng, N., Yang, K., Bayan, J., He, L., Aggarwal, R., Stiles, J. W., Hou, X., Medina, V., Abad, D., Palian, B. M., et al. (2013) · Aging Cell · doi:10.1111/acel.12132 · Cited by 50
Jiang, W., Peng, Y., & Yang, K. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6603 · Cited by 50
Molecular basis for the regulation of islet beta cell mass in mice: the role of E-cadherin
Wakae-Takada, N., Xuan, S., Watanabe, K., Meda, P., & Leibel, R. L. (2013) · Diabetologia · doi:10.1007/s00125-012-2824-6 · Cited by 48
Berent-Maoz, B., Montecino-Rodriguez, E., Signer, R. A. J., & Dorshkind, K. (2012) · Blood · doi:10.1182/blood-2011-12-400002 · Cited by 46
Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions
Shen, W., He, J., Hou, T., Si, J., & Chen, S. (2022) · Aging and Disease · doi:10.14336/ad.2021.1208 · Cited by 45
Metadata
- Authors
- Chen, H., Gu, X., Liu, Y., Wang, J., Wirt, S. E., Bottino, R., Schorle, H., Sage, J., & Kim, S. K.
- Affiliations
- Stanford Medicine (US)
- University of Pittsburgh (US)
- University of Bonn (DE)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Kim, Seung K.
- ORCID
- Venue
- Nature
- Published
- 2011-10
- Volume
- 478
- Issue
- 7369
- Pages
- 349-355
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3503246
- OpenAlex
- W2061620419
- Cited by
- 278
- References
- 44
- Citations by year
- 2026: 5 · 2025: 17 · 2024: 11 · 2023: 17 · 2022: 12 · 2021: 13 · 2020: 17 · 2019: 18 · 2018: 17 · 2017: 24 · 2016: 23 · 2015: 23 · 2014: 22 · 2013: 37 · 2012: 22
- FWCI
- 26.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Foundation for the National Institutes of Health
- Howard Hughes Medical Institute
- Stem Cell Network
- Deutsche Krebshilfe
- National Cancer Institute (R01CA114102, T32CA009302)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK089532, U01DK089572, U01 DK89572, R01DK056709, R01DK075919, U01 DK89532, R01DK072184)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- PDGF signaling, platelet-derived growth factor receptor, pancreatic beta cells, beta-cell proliferation, aging, EZH2, beta-cell expansion, islets, diabetes treatment, ERK1/2 phosphorylation, conditional gene inactivation, human islets
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, Age Factors, Animals, Cells, Cultured, Diabetes Mellitus, Experimental, Female, Humans, Male, Mice, Inbred C57BL, Histone-Lysine N-Methyltransferase, Signal Transduction, Gene Expression Regulation, Enzymologic, Retinoblastoma Protein, Receptors, Platelet-Derived Growth Factor, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinase 3, Cell Proliferation, Insulin-Secreting Cells, E2F Transcription Factors, Mice, Gene Knockout Techniques, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
